The Psychedelics Renaissance of 2020 is Seemingly Happening at a Perfect Time During This Year of Many Firsts More and More People Are Facing Mental Health Issues Related to the... read more →
Champignon Brands' CRTCE Clinic is the First Multidisciplinary Community Clinic in Canada to Offer Rapid-Onset Treatments for Depression and Expects to Be the First of its Kind to Provide the... read more →
Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of July 20th – 26th, 2020.... read more →
Any New Drug Therapy That Can Be Manufactured and Sold in the United States Has to Have the Approval of the U.S. FDA. That’s the Deal. Without That Approval, Which... read more →
Psychedelics Companies That Own Clinics May Hold the Answer to One of the Top Investor Questions: "How Will Individual Firms Generate Meaningful Revenue?" As We Know, the Business of Biotech... read more →
Surging Investor Demand Continues to Be Concentrated into a Limited Number of Psychedelic Stocks As the Psychedelics Industry Continues to Blossom, the Current Circumstances Have Created a Situation for Investors... read more →
Champignon Advances Psychedelic Clinic Expansion Announcing Terms for First U.S. Acquisition of California-Based Wellness Clinic of Orange County Today's News Comes Just One Day After the Psychedelics Company Announced Dr.... read more →
